ArticleScientific reports2026
Unsupervised cluster analysis identifies risk profiles driving heterogeneity and survival patterns in aortic aneurysm patients.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Aortic aneurysms (AAs) are influenced by diverse modifiable and non-modifiable risk factors. The underlying heterogeneity in this patient population complicates efforts to optimize risk stratification. Phenomapping leverages unsupervised clustering algorithms to group similar patients based on phenotypic profiles and can identify homogenous clusters in complex data patterns. While clinical classification typically relies on aneurysm morphology and presentation, unsupervised phenomapping could uncover alternative, data-driven risk profiles. Unsupervised clustering (k-means) utilizing data from the UK Biobank was conducted. All patients recorded with aortic pathologies (ICD-10 group I71) were included. Clustering variables encompassed demographic and clinical parameters, emphasizing relevant comorbidities. The main analyses were conducted in abdominal AA, whereas validation analyses were conducted in the remaining aortic pathologies. The primary outcome was all-cause mortality. The study population consisted of 4623 participants (21.2% female), including abdominal (66.9%), thoracic (25.4%), and thoracoabdominal AA (0.5%), as well as aortic dissections (7.2%). Cardiovascular comorbidity emerged as the primary driver of cluster differentiation both in the main and validation analysis outweighing morphological differences. Survival analysis highlighted higher all-cause mortality rates in these multimorbid clusters. Cardiovascular and renal comorbidities can be leveraged in an informative comorbidity index. The non-linear increase in mortality risk may be indicative of the superimposed effects of the aortic pathology itself. Cardiorenal multimorbidity appears to be the most relevant separator between AA patients. However, the burden of disease associated with an aortic pathology itself relevantly impacts mortality risk estimation based on these comorbidities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.